Table 2. Correlations of patients with NAFLD.
| Varibles | εdA | 4 HNE | CYP2E1 | Steatosis | Inflammation | Fibtosis | DM | AST | ALT | GGT |
|---|---|---|---|---|---|---|---|---|---|---|
| εdA | 1 | 0.466** | −0.140 | 0.79 | 0.145 | −0.370 | −0.220 | −0.133 | −0.193 | −0.154 |
| 4 HNE | − | 1 | −0.171 | 0.036 | 0.068 | −0.072 | −0.200 | 0.052 | −0.166 | 0.780 |
| CYP2E1 | − | − | 1 | 0.188 | 0.206 | 0.303 | −0.009 | 0.103 | −0.530 | 0.220 |
| Steatosis | − | − | − | 1 | 0.582** | 0.671** | 0.331* | −0.760 | 0.028 | −0.250 |
| Inflammation | − | − | − | − | 1 | 0.668** | 0.449** | 0.129 | 0.160 | −0.320 |
| Fibtosis | − | − | − | − | − | 1 | 0.460** | −0.920 | −0.110 | −0.269 |
| DM | − | − | − | − | − | − | 1 | −0.650 | 0.170 | 0.168 |
| AST | − | − | − | − | − | − | − | 1 | 0.741** | 0.387* |
| ALT | − | − | − | − | − | − | − | − | 1 | 0.107 |
| GGT | − | − | − | − | − | − | − | − | − | 1 |
Data represent Spearman correlation coefficient, *, P<0.05; **, P<0.01; NAFLD, nonalcoholic fatty liver disease; εdA, etheno-2'-deoxyadenosine; 4 HNE, 4-hydroxynonenal; CYP2E1, cytochrome P450 2E1; DM, diabetes mellitus; AST, aspartate aminotransferase; ALT, alaninamino transferase; GGT, gamma glutamyltransferase.